LFMD Investors Urged to Participate in Class Action Against LifeMD Securities Fraud

LifeMD Securities Fraud Lawsuit Overview

In a significant legal development for investors, The Rosen Law Firm has invited those who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) during the period from May 7 to August 5, 2025, to participate in a class action lawsuit concerning alleged securities fraud. The firm emphasizes that investors may qualify for compensation without incurring any legal fees upfront, based on a contingency fee model.

Key Details of the Case

The class action lawsuit has been initiated due to accusations that various defendants made misleading statements and failed to disclose pertinent information throughout the designated class period. Specifically, it is alleged that LifeMD overstated its competitive position and provided optimistic financial guidance without adequately addressing the rising costs associated with acquiring new customers, particularly in its RexMD segment. Furthermore, the lawsuit highlights that the company’s claims regarding drug sales, including those for obesity treatments such as Wegovy and Zepbound, lacked a reasonable basis, leading to tangible losses for investors once the truth was revealed to the market.

Call to Action

Interested parties are encouraged to act swiftly as the deadline to apply as lead plaintiff is set for October 27, 2025. Those looking to take a leading role in the litigation must file their motions with the court by this date. As a lead plaintiff, an investor represents the interests of other class members in directing the course of the lawsuit.

For investors wishing to join the class action, The Rosen Law Firm has provided resources for registration, including a form on their website and contact information for legal assistance. The firm has a long-standing reputation in handling securities class actions, having secured substantial settlements for thousands of investors in the past. Notably, the firm was ranked first for the number of securities class action settlements as of 2017, further establishing its credibility in this field.

Selecting Legal Representation

The Rosen Law Firm urges potential investors to carefully consider their choice of legal representation, especially given that many firms may lack the necessary experience in actively litigating such cases. The firm prides itself on its track record and advises investors to select qualified counsel, emphasizing its history of substantial recoveries for its clients, including hundreds of millions of dollars over recent years.

Conclusion

As the legal proceedings unfold, it is crucial for affected investors to stay informed and take appropriate action to protect their interests. This class action offers an avenue for investors to seek reparations against LifeMD, and those who believe they have been wronged should not hesitate to explore their options through The Rosen Law Firm.

To enroll in the class action or inquire further, investors can visit Rosen Legal or reach out via phone or email. Following developments on social media channels such as LinkedIn, Twitter, and Facebook is also encouraged to keep abreast of important updates regarding this ongoing legal matter.